Identity, assay, purity and impurity profiling of active pharmaceutical ingredients, excipients and starting materials — to USP, Ph. Eur. and BP monograph methods, or to client-specific specifications. Supports incoming-goods release, supplier qualification and dossier preparation.
API identity, assay and purity (HPLC, UPLC, LC-MS, FTIR, NMR-supported referrals)
Related substances and impurity profiling against ICH Q3A / Q3B
Residual solvents per ICH Q3C / USP <467>
Elemental impurities per ICH Q3D / USP <232>/<233>
Water content (Karl Fischer), loss on drying
Particle size, polymorph identification (XRD on referral)
Excipient testing to compendial monographs
Supplier-comparability and incoming-goods release
Compendial and validated assay, related-substances and content methods.
Trace impurity identification and quantification.
Residual solvents per ICH Q3C; volatile impurities.
Elemental impurities to ICH Q3D Class 1/2A/2B/3.
Identity confirmation against reference standard or library spectrum.
Coulometric water content for hygroscopic and non-aqueous samples.
Compendial titrations, pH, optical rotation, refractive index.
Where API monographs require it (USP <61>, <62>, Ph. Eur. 2.6.12, 2.6.13).
Methods, documentation and acceptance criteria are designed to align with the standards below. This describes design intent — formal accreditations are listed on the About page.
Compendial CoA for each batch
Impurity profile aligned to ICH Q3A / Q3B reporting thresholds
Residual solvents and elemental impurities reports
Supplier qualification / comparability report
Investigation report when results fall outside specification
Compendial monograph cross-walk for legacy methods
Send a short scope and we'll come back with a quote and indicative timeline within one working day.